{"slug": "ai-medical-scribe-build-vs-buy-nuance-dax-abridge", "title": "AI Medical Scribe: Build vs Buy Nuance DAX & Abridge", "summary": "A developer at AssemblyAI argues that healthcare AI teams face a strategic choice between buying finished ambient clinical documentation products like Nuance DAX Copilot or Abridge and building their own. Buying offers speed and compliance but sacrifices control over note format, specialty coverage, and margins, while building requires significant work but provides ownership and differentiation. The developer emphasizes that the speech-to-text foundation is the critical layer for a trustworthy scribe.", "body_md": "Every healthcare AI team lands on the same question eventually. You want ambient clinical documentation in your product, and there are two obvious paths. Buy a finished scribe like Nuance DAX Copilot or Abridge and wire it in. Or build your own.\n\nHere's the reframe most comparison posts miss. DAX and Abridge are finished products. They're good ones. If you're a health system that wants a scribe in clinicians' hands next quarter and you're never going to differentiate on documentation itself, buying is often the right call. Full stop.\n\nBut if you're a product team building a clinical application, a specialty EHR, or an ambient scribe you plan to sell, the \"which scribe do I buy\" question is the wrong one. You're not shopping for a scribe. You're deciding whether documentation is a feature you own or a feature you rent. And if you build, the question becomes: what do you build on?\n\nThat's the fork. Let's walk it honestly.\n\nWhen you buy DAX or Abridge, you get a lot the same day: a working scribe, a note format clinicians already recognize, EHR integrations, a compliance posture, and a vendor who owns the roadmap. That's real value, and pretending otherwise is a mistake.\n\nWhat you give up is control. The note format is theirs. The specialties they support are theirs. The pace of improvement is theirs. And the economics are per-seat, per-provider, forever—which means your gross margin on documentation is capped by someone else's price list.\n\nWhen you build, you flip every one of those. You own the note structure, the specialty coverage, the UX, the model choices underneath, and the margin. You also own the work: accurate medical transcription, speaker separation, note generation, and compliance. That's not a weekend project. But none of it is mysterious anymore, and most of the hard part isn't where teams expect.\n\nThe sticker price is the easy part. The real costs show up later.\n\n**Margin.** Per-seat pricing scales with your clinician count, not your efficiency. Get 10,000 providers on the platform and your documentation cost grows linearly right alongside. You can't engineer that number down because you don't own the stack.\n\n**Control over the note.** Cardiology notes and behavioral health notes shouldn't look the same. If your differentiation is a note tuned to a specialty or a workflow, a general-purpose scribe fights you on it. You file feature requests and wait.\n\n**Lock-in.** Once your workflows, integrations, and clinician muscle memory are built around a vendor's output format, switching is a migration project, not a config change. That's leverage—theirs, not yours.\n\n**Differentiation.** If you and three competitors all ship the same underlying scribe, documentation stops being a reason anyone chooses you. It becomes table stakes you're paying a premium to rent.\n\nNone of this makes buying wrong. It makes buying a strategic decision about where your product's value actually lives. If documentation isn't your edge, rent it and move on. If it is—or could be—renting your core is a strange way to build a company.\n\nAn ambient scribe is a pipeline, and it's shorter than it looks. Four layers.\n\nHere's the part that surprises people. The LLM layer, the part everyone's excited about, is the most commoditized. Strong models are a few API calls away, and prompt engineering a good SOAP note is tractable. The layer that quietly decides whether your scribe is trustworthy is the first one—the [speech-to-text](https://www.assemblyai.com/products/speech-to-text) foundation. Garbage transcript in, confident-sounding garbage note out. An LLM will happily summarize a hallucinated dosage into a clean, plausible sentence a clinician might sign.\n\nSo the build decision is really a decision about your transcription layer. Get that right and the rest of the pipeline has something solid to stand on.\n\nThis is the input that determines everything, so it's worth being specific about what \"good enough for clinical\" means.\n\n**Medical accuracy that isn't generic.** General speech-to-text mangles clinical vocabulary—that's the whole problem. AssemblyAI's [Universal-3.5 Pro](https://www.assemblyai.com/blog/universal-3-5-pro-async) is the flagship async model at $0.21/hr, and you turn on medical accuracy by adding one parameter: \"domain\": \"medical-v1\". That's Medical Mode, +$0.15/hr, so the flagship plus Medical Mode runs $0.36/hr combined. It reduces the Missed Entity Rate on drugs, conditions, procedures, and clinical terms by roughly 20%. No model switch, no separate pipeline—one param on the model you're already calling.\n\n**Context that adapts to the patient.** Medical Mode gets you baseline clinical accuracy. Contextual prompting gets you the last mile. Prime the model with a patient's prior-visit note and it knows what to listen for. In an internal healthcare test, feeding a prior-visit note cut missed medical terms by 31%—even when the note was from an earlier visit. That's the kind of gain you can't buy off a shelf because it depends on data only your application has.\n\n**Diarization built in.** Universal-3.5 Pro produces the transcript and the speaker turns together—the most accurate diarization we've shipped, optimized for cpWER and tuned for the short turns, rapid exchanges, and overlapped speech of an actual exam room. You're not bolting on a separate speaker model and hoping the timestamps line up.\n\n**A streaming option when you need it.** Most ambient scribes are async—record the visit, generate the note. But if you're building live documentation, a real-time assistant, or clinician-facing prompts mid-visit, [Universal-3.5 Pro Realtime](https://www.assemblyai.com/blog/universal-3-5-pro-realtime) offers Medical Mode too, with live diarization. Same foundation, real-time shape. That flexibility matters when your roadmap outgrows batch processing.\n\n**Languages.** Medical Mode supports English, Spanish, German, and French—so a Spanish-language visit gets clinical-grade transcription, not a downgrade.\n\nCompare that to buying: with DAX or Abridge, the transcription layer is a black box. You can't tune it, you can't prompt it with your data, and you can't fix it when it's wrong on a term that matters to your specialty. Building on a foundation you control means the accuracy ceiling is yours to raise. If you want the deeper argument for why this input dominates outcomes, we made it in [the true cost of inaccurate transcription](https://www.assemblyai.com/blog/true-cost-of-inaccurate-transcription) and in why [transcription accuracy and transcription quality](https://www.assemblyai.com/blog/transcription-accuracy-vs-transcription-quality) aren't the same thing.\n\nCompliance is where \"build\" teams get nervous, and fair enough—PHI is not the place to improvise. The good news is that the transcription layer of your stack can carry a clean posture.\n\nAssemblyAI enables covered entities and their business associates subject to HIPAA to use the AssemblyAI services to process protected health information (PHI). AssemblyAI is considered a business associate under HIPAA, and we offer a Business Associate Addendum (BAA) that is required under HIPAA to ensure that AssemblyAI appropriately safeguards PHI.\n\nPractically, that BAA is available to sign without booking a sales call—so a compliance review doesn't turn into a procurement saga before you've written a line of code. For teams with data-residency requirements, EU processing is available too. Compliance is table stakes, but it shouldn't be the thing that slows your build to a crawl.\n\nHere's the comparison that actually matters—not a spec smackdown, but the strategic trade-offs.\n\n| Decision criterion | Buy (DAX / Abridge) | Build (on AssemblyAI) |\n|---|---|---|\n| Control over note format & UX | Vendor-defined; feature requests | Fully yours — tune per specialty and workflow |\n| Gross margin on documentation | Capped by per-seat pricing | Yours to engineer; usage-based inputs |\n| Time-to-market | Fastest — finished product | Longer, but the STT layer is an API call |\n| Differentiation | Shared with everyone on the same scribe | Documentation becomes a product edge |\n| Compliance ownership | Vendor's posture | Your posture; BAA available on the STT layer |\n| Cost model | Per-seat, per-provider, recurring | Pay-as-you-go on transcription ($0.36/hr with Medical Mode) |\n| Roadmap & pace of improvement | Vendor's priorities | Yours |\n| Best fit | Orgs that won't differentiate on docs | Product teams selling or owning the experience |\n\n**Buy DAX or Abridge if:** you're a health system or clinic that needs a working scribe in clinicians' hands fast, documentation isn't part of your competitive story, and you'd rather pay per seat than staff an engineering team against it. That's a legitimate, common, correct choice. These are mature products for exactly this buyer.\n\n**Build if:** documentation is part of what you sell, you need note formats or specialty coverage a general scribe won't give you, per-seat economics break your margin at scale, or you're already a software company and owning the stack is how you compete. In that case, the smart move isn't building transcription from scratch—it's building on a transcription layer that's already solved medical accuracy, diarization, and compliance, so your team spends its time on the note logic and product experience that actually differentiate you.\n\nHealthcare teams building their own documentation experiences tend to land in the second camp for the same reason: they want the margin and the control, and they don't want to reinvent speech-to-text to get there.\n\nRun your project through these before committing:\n\nIf you're weighing the broader landscape, our guides on [Voice AI for healthcare market research](https://www.assemblyai.com/blog/how-to-use-speech-ai-for-healthcare-market-research) and [conversation intelligence](https://www.assemblyai.com/blog/conversation-intelligence) show how the same speech foundation extends well past the exam room. For the numbers behind the models, the [benchmarks](https://www.assemblyai.com/benchmarks) and our take on [how accurate speech-to-text is in 2026](https://www.assemblyai.com/blog/how-accurate-speech-to-text) are the receipts.\n\n[ Explore Voice AI solutions](https://www.assemblyai.com/products) to see the full platform under a scribe you own—or dig into the\n\nHere's the thing nobody tells you at the start. Build vs buy isn't a one-time decision—it's a decision that gets more expensive to reverse the longer you wait. The team that buys \"to move fast\" and plans to build later usually can't—by then their workflows, integrations, and clinician habits are welded to a vendor's format. And the team that builds on a weak transcription layer finds the ceiling only after shipping, when clinicians stop trusting the notes.\n\nSo the real move is to decouple the decision. Even if you buy a finished scribe today, own the layer that's hardest to swap later—your speech-to-text foundation—so building stays a live option instead of a fantasy. Accuracy compounds. Lock-in compounds. Pick the one you want on your side.\n\nBuy if you need a finished scribe fast and documentation isn't your competitive edge—DAX and Abridge are mature products built for that. Build if documentation is part of what you sell, you need custom note formats or specialty coverage, per-seat pricing breaks your margin at scale, or you want to own the experience. If you build, don't build transcription from scratch—build on a medical-grade speech-to-text layer and spend your effort on note logic and UX.\n\nAssemblyAI enables covered entities and their business associates subject to HIPAA to use the AssemblyAI services to process protected health information (PHI). AssemblyAI is considered a business associate under HIPAA, and we offer a Business Associate Addendum (BAA) that is required under HIPAA to ensure that AssemblyAI appropriately safeguards PHI. The BAA is available to sign without a sales call.\n\nUniversal-3.5 Pro with Medical Mode (\"domain\": \"medical-v1\") reduces the Missed Entity Rate on drugs, conditions, procedures, and clinical terms by roughly 20%. Contextual prompting goes further—feeding a patient's prior-visit note cut missed medical terms by 31% in an internal healthcare test, even when the note came from an earlier visit.\n\nTranscription is pay-as-you-go, billed per second with no minimums. Universal-3.5 Pro async is $0.21/hr, and Medical Mode adds $0.15/hr—so the flagship plus Medical Mode is $0.36/hr combined. That's a usage-based input cost you control, versus the recurring per-seat pricing of a finished scribe.\n\nEnglish, Spanish, German, and French. Medical Mode is available on Universal-3.5 Pro (async) and on Universal-3.5 Pro Realtime for streaming use cases.\n\nAdd \"domain\": \"medical-v1\" to a Universal-3.5 Pro request and run it against your own clinical audio. Sign the BAA when you're ready to process PHI, and check the [medical solution page](https://www.assemblyai.com/solutions/medical) for the full picture.", "url": "https://wpnews.pro/news/ai-medical-scribe-build-vs-buy-nuance-dax-abridge", "canonical_source": "https://dev.to/martschweiger/ai-medical-scribe-build-vs-buy-nuance-dax-abridge-53hk", "published_at": "2026-07-22 14:55:23+00:00", "updated_at": "2026-07-22 15:01:41.561343+00:00", "lang": "en", "topics": ["artificial-intelligence", "natural-language-processing", "ai-products", "ai-infrastructure", "developer-tools"], "entities": ["AssemblyAI", "Nuance DAX Copilot", "Abridge"], "alternates": {"html": "https://wpnews.pro/news/ai-medical-scribe-build-vs-buy-nuance-dax-abridge", "markdown": "https://wpnews.pro/news/ai-medical-scribe-build-vs-buy-nuance-dax-abridge.md", "text": "https://wpnews.pro/news/ai-medical-scribe-build-vs-buy-nuance-dax-abridge.txt", "jsonld": "https://wpnews.pro/news/ai-medical-scribe-build-vs-buy-nuance-dax-abridge.jsonld"}}